Skip to main content
. 2012 Dec 12;2012(12):CD001423. doi: 10.1002/14651858.CD001423.pub3

Marks 2000.

Methods Single‐site study 
 Randomization: table of random numbers 
 Blinding: patients
Participants Geographic region: USA 
 Study setting: community 
 N = 44 
 Baseline IPSS: Saw palmetto herbal blend 18.4; placebo 16.4 
 Baseline prostate volume: Saw palmetto herbal blend 58.5 cc; placebo 55.6 cc 
 Mean age (range): 64 (45 to 80) years 
 Race: White 73%, Black 7%, Asian 11% 
 Diagnostic criteria: moderate to severe BPH with enlarged prostate (DRE), IPSS score of 9 or greater, PSA < 15 ng/mL, prostate volume 30 cc or greater.
Interventions Control: placebo 
 Treatment: Saw palmetto herbal blend (saw palmetto 106 mg, nettle root extract 80 mg, pumpkin seed oil extract 160 mg, vitamin A 190 mg) thrice daily 
 Study duration: 6 months 
 Lost to follow‐up: 7%
Outcomes Symptom improvement ‐ IPSS symptom score 
 Peak urine flow 
 Post‐void residual volume 
 PSA 
 Prostate volume 
 Dropouts due to side effects: None
Notes Exclusions: concurrent use of α‐blockers; use of finasteride, phytotherapy within last 18 months or α‐blockers within last month; chronic prostatitis; previous bladder or prostate surgery; neurogenic bladder
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk adequate
Allocation concealment (selection bias) Low risk adequate
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk adequate
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk not mentioned
Incomplete outcome data (attrition bias) 
 All outcomes High risk per protocol analysis
Selective reporting (reporting bias) Low risk adequate
Other bias Low risk adequate